Follow
Thirumaran Senguttuvan
Thirumaran Senguttuvan
MPH Candidate, Columbia University
Verified email at nirt.res.in - Homepage
Title
Cited by
Cited by
Year
Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial
RL Goodall, SK Meredith, AJ Nunn, A Bayissa, AK Bhatnagar, G Bronson, ...
The Lancet 400 (10366), 1858-1868, 2022
562022
Predictors of mortality among hospitalized COVID-19 patients and risk score formulation for prioritizing tertiary care—An experience from South India
N Gopalan, S Senthil, NL Prabakar, T Senguttuvan, A Bhaskar, ...
PLoS One 17 (2), e0263471, 2022
432022
Characteristics of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome and its influence on tuberculosis treatment outcomes in persons living with HIV
G Narendran, K Jyotheeswaran, T Senguttuvan, CL Vinhaes, ...
International Journal of Infectious Diseases 98, 261-267, 2020
102020
Factors associated with unexplained sudden deaths among adults aged 18-45 years in India–A multicentric matched case–control study
M Ponnaiah, T Bhatnagar, RS Abdulkader, R Elumalai, J Surya, ...
Indian journal of medical research 158 (4), 351-362, 2023
42023
Predictors of unfavorable responses to therapy in rifampicin-sensitive pulmonary tuberculosis using an integrated approach of radiological presentation and sputum mycobacterial …
N Gopalan, VA Srinivasalu, P Chinnayan, B Velayutham, A Bhaskar, ...
Plos one 16 (9), e0257647, 2021
22021
Paradoxical Tuberculous Immune Reconstitution Inflammatory Syndrome (TB-IRIS) in HIV with culture positive rifampicin-sensitive pulmonary TB-Risk factors and influence on TB …
N Gopalan, PA Menon, P Chandrashekaran, VA Srinivasalu, ...
The system can't perform the operation now. Try again later.
Articles 1–6